← Leaderboards
Robert G Lowery
Panvera Corporation
$15,780,035
Attributed
$16,010,003
Total exposure
31
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$16,010,003 · 31
By mechanism
R44$11,192,999 · 11
R43$3,966,568 · 17
R41$459,936 · 2
R21$390,500 · 1
Top collaborators
- David J Beebe1 shared
- Jennifer Margaret Heemstra1 shared
Others in their field
Top investigators on “Detection”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Francis L Halzen · University Of Wisconsin-Madison$243,423,219
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Richard A Gibbs · Baylor College Of Medicine$209,716,260
- Richard K. Wilson · Washington University$206,265,868
- Craig B Thompson · Sloan-Kettering Inst Can Research$156,512,301
Research focus
DetectionDrug DiscoveryBaseHigh Throughput ScreeningSmall MoleculeInhibitor/AntagonistSignal TransductionReagentFluorescence PolarizationAntibodiesEnzymesPharmaceutical PreparationsCellsProteinsBiochemicalMalignant NeoplasmsProductionLeadReactionFluorescence Resonance Energy TransferTissuesScreening ProcedureComplexBinding
Grant awards (42)
Chemically Induced Dimerization Systems for High Throughput Enzyme Assays$270,929
R43 · FY2024 · GM · contact PI
Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases$832,430
R44 · FY2022 · AI · contact PI
Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases$988,840
R44 · FY2021 · AI · contact PI
Targeting a Human Acyltransferase for Broad-Spectrum Antivirals$390,500
R21 · FY2021 · AI · contact PI
Discovery of TREX1 Antagonists for Cancer Immunotherapy$300,000
R43 · FY2020 · CA · contact PI
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer$416,339
R44 · FY2019 · GM · contact PI
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer$328,984
R44 · FY2019 · GM · contact PI
Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases$300,000
R43 · FY2019 · AI · contact PI
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer$591,712
R44 · FY2018 · GM · contact PI
Riboswitch Based Methyltransferase HTS Assay for Epigenetic Drug Discovery$390,213
R44 · FY2017 · GM · contact PI
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer$288,683
R43 · FY2017 · GM · contact PI
Riboswitch Based Methyltransferase HTS Assay for Epigenetic Drug Discovery$470,463
R44 · FY2016 · GM · contact PI
Pharmacological Validation of GIV/Girdin, a Guanine Nucleotide Exchange Factor, for Liver Fibrosis$353,332
R43 · FY2016 · AA · contact PI
Streamlining HTS Assay Development through Direct Selection of Structure-Switching Aptamers$234,936
R41 · FY2016 · GM · contact PI
Axonal Transport HTS Platform for Neurodegeneration Drug Discovery$225,000
R41 · FY2015 · NS · contact PI
Fluorescent biosensors for dynamic monitoring of paracrine signaling in extracellular matrix$224,999
R43 · FY2015 · NS · contact PI
Riboswitch Based Methyltransferase HTS Assay for Epigenetic Drug Discovery$224,931
R43 · FY2014 · GM · contact PI
Screening Device for Differentiated Primary Cell Models of Airway Epithelia$194,007
R44 · FY2013 · HL · contact PI
Screening Device for Differentiated Primary Cell Models of Airway Epithelia$539,579
R44 · FY2012 · HL · contact PI
High Throughput Assay for Detecting Protein Modifications in Cell Lysates$272,419
R43 · FY2011 · GM · contact PI
HTS Assays for Modulators of GPCR Signaling$701,073
R44 · FY2010 · NS · contact PI
Intramolecular Immunoassay for Probing Paracrine Signaling$250,859
R43 · FY2010 · GM · contact PI
HTS Assays for Modulators of GPCR Signaling$671,897
R44 · FY2009 · NS · contact PI
Fluorescent HTS Assays for Methyltransferases in Neurodegenerative Diseases$458,750
R44 · FY2009 · GM · contact PI
Enhanced ADP Immunoassay for Multimode Kinase Detection$192,952
R43 · FY2009 · GM · contact PI
Fluorescent HTS Assays for Methyltransferases in Neurodegenerative Diseases$363,398
R44 · FY2008 · GM · contact PI
Generic Fluorescent HTS Assay for Oxidoreductases$210,100
R43 · FY2008 · GM · contact PI
Generic Fluorescent HTS Assay for Kinases and ATPases$257,753
R44 · FY2007 · CA · contact PI
HTS Assays for Modulators of GPCR Signaling$235,189
R43 · FY2007 · NS · contact PI
Fluorescent HTS Assays for Human Sulfotransferases$475,995
R44 · FY2006 · GM · contact PI
Generic Fluorescent HTS Assay for Kinases and ATPases$390,536
R44 · FY2006 · CA · contact PI
Fluorescent HTS Assay for Methyltransferases in Neurodegenerative Diseases$163,177
R43 · FY2006 · GM · contact PI
Fluorescent HTS Assays for Human Sulfotransferases$545,659
R44 · FY2005 · GM
Microfluidic Reconstituted Mammary Tissue System$252,748
R43 · FY2005 · DE
Generic Fluorescent HTS Assay for Protein Kinases$173,113
R43 · FY2005 · CA
High Throughput Assays for Drug Glucuronidation$468,607
R44 · FY2003 · GM
Fluorescent HTS Assays for Human Sulfotransferases$207,918
R43 · FY2003 · GM
High Throughput Assays for Drug Glucuronidation$708,643
R44 · FY2002 · GM
HTS ASSAYS FOR SELECTIVE STEROID RECEPTOR MODULATORS$456,056
R44 · FY2001 · DK
HTS ASSAYS FOR SELECTIVE STEROID RECEPTOR MODULATORS$583,144
R44 · FY2000 · DK
HIGH THROUGHPUT SCREENING ASSAYS FOR P450 METABOLISM$358,921
R44 · FY2000 · CA
STRUCTURE BASED PREDICTION OF DRUG GLUCURONIDATION$45,219
R43 · FY2000 · GM